Literature DB >> 18348450

Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.

Ulrike Leiter1, Claus Garbe.   

Abstract

Melanoma and nonmelanoma skin cancer (NMSC) are now the most common types of cancer in white populations. Both tumor entities show an increasing incidence rate worldwide but a stable or decreasing mortality rate. The rising incidence rates of NMSC are probably caused by a combination of increased sun exposure or exposure to ultraviolet (UV) light, increased outdoor activities, changes in clothing style, increased longevity, ozone depletion, genetics and in some cases, immune suppression. A dose-dependent increase in the risk of squamous cell carcinoma (SCC) of the skin was found associated with exposure to Psoralen and UVA irradiation. An intensive UV exposure in childhood and adolescence was causative for the development of basal cell carcinoma (BCC) whereas for the aetiology of SCC a chronic UV exposure in the earlier decades was accused. Cutaneous malignant melanoma is the most rapidly increasing cancer in white populations. The frequency of its occurrence is closely associated with the constitutive colour of the skin and depends on the geographical zone. The highest incidence rates have been reported from Queensland, Australia with 56 new cases per year per 100,000 for men and 43 for women. Mortality rates of melanoma show a stabilisation in the USA, Australia and also in European countries. The tumor thickness is the most important prognostic factor in primary melanoma. There is an ongoing trend towards thin melanoma since the last two decades. Epidemiological studies have confirmed the hypothesis that the majority of all melanoma cases are caused, at least in part, by excessive exposure to sunlight. In contrast to squamous cell carcinoma, melanoma risk seems not to be associated with cumulative, but intermittent exposure to sunlight. Therefore campaigns for prevention and early detection are necessary.

Entities:  

Mesh:

Year:  2008        PMID: 18348450     DOI: 10.1007/978-0-387-77574-6_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  171 in total

Review 1.  Dissecting the bulge in hair regeneration.

Authors:  Peggy Myung; Mayumi Ito
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

Review 2.  [The aged scalp : A dermato-oncological focus point].

Authors:  N Wroblewski; K Wylon; C Ulrich
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

Review 3.  Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma.

Authors:  Joel M Mor; Ludwig M Heindl
Journal:  Ocul Oncol Pathol       Date:  2016-12-08

4.  Cancer incidence in a cohort of Swedish chimney sweeps, 1958-2006.

Authors:  Christer Hogstedt; Catarina Jansson; Marcus Hugosson; Håkan Tinnerberg; Per Gustavsson
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

5.  A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.

Authors:  Feng Liu; Leona Bessonova; Thomas H Taylor; Argyrios Ziogas; Frank L Meyskens; Hoda Anton-Culver
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-21       Impact factor: 4.693

6.  Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimen.

Authors:  Ahmed E Othman; Thomas K Eigentler; Georg Bier; Christina Pfannenberg; Hans Bösmüller; Christian Thiel; Claus Garbe; Konstantin Nikolaou; Bernhard Klumpp
Journal:  Eur Radiol       Date:  2016-10-17       Impact factor: 5.315

7.  Comparative analysis of the relative potential of silver, Zinc-oxide and titanium-dioxide nanoparticles against UVB-induced DNA damage for the prevention of skin carcinogenesis.

Authors:  Nikhil Tyagi; Sanjeev K Srivastava; Sumit Arora; Yousef Omar; Zohaib Mohammad Ijaz; Ahmed Al-Ghadhban; Sachin K Deshmukh; James E Carter; Ajay P Singh; Seema Singh
Journal:  Cancer Lett       Date:  2016-09-28       Impact factor: 8.679

8.  Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.

Authors:  Millie D Long; Hans H Herfarth; Clare A Pipkin; Carol Q Porter; Robert S Sandler; Michael D Kappelman
Journal:  Clin Gastroenterol Hepatol       Date:  2010-01-16       Impact factor: 11.382

Review 9.  The discovery and development of binimetinib for the treatment of melanoma.

Authors:  Brian Tran; Mark S Cohen
Journal:  Expert Opin Drug Discov       Date:  2020-04-04       Impact factor: 6.098

10.  A comprehensive catalogue of somatic mutations from a human cancer genome.

Authors:  Erin D Pleasance; R Keira Cheetham; Philip J Stephens; David J McBride; Sean J Humphray; Chris D Greenman; Ignacio Varela; Meng-Lay Lin; Gonzalo R Ordóñez; Graham R Bignell; Kai Ye; Julie Alipaz; Markus J Bauer; David Beare; Adam Butler; Richard J Carter; Lina Chen; Anthony J Cox; Sarah Edkins; Paula I Kokko-Gonzales; Niall A Gormley; Russell J Grocock; Christian D Haudenschild; Matthew M Hims; Terena James; Mingming Jia; Zoya Kingsbury; Catherine Leroy; John Marshall; Andrew Menzies; Laura J Mudie; Zemin Ning; Tom Royce; Ole B Schulz-Trieglaff; Anastassia Spiridou; Lucy A Stebbings; Lukasz Szajkowski; Jon Teague; David Williamson; Lynda Chin; Mark T Ross; Peter J Campbell; David R Bentley; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.